NuScale PowerSMRRevenue: is the business selling more than it used to?
$31M−15% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Revenue reached $31M in 2025, compounding +39% a year since 2022 though the pace has cooled. The last twelve months (-81%) ran below that pace, so growth is slowing. The trailing twelve months are already running at $11M, behind the last full year.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRNet income: how much of that revenue becomes profit?
$-356MFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→The company lost $356M in 2025, more than the $137M it lost the year before. The losses are widening - check the Health chapter for how long the cash lasts.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRHow fast is it growing, year by year?
-15.0%revenue growth, FY 2025
→Revenue grew -15% in 2025 against a five-year average of +166%.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRRevenue per share: is your slice growing as fast as the company?
$0.19revenue per share, FY 2025
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→Revenue per share reached $0.19 in 2025, compounding -6% a year against +39% for SMR as a whole. Dilution absorbed about 44.8 points of that growth. Free cash flow per share stands at $-2.81.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRFree cash flow: what is left in real cash after everything?
$-460MFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→The business consumed $460M of cash in 2025 after investment. Growth is being funded from the balance sheet, not from operations.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRWhere does each dollar of revenue actually go?
→Of $31M in 2025 sales, nothing survives to the bottom line - the journey ends $356M underwater.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRHow much of every sales dollar ends up as free cash?
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Free cash flow is negative, so no share of revenue is currently converting to spare cash. Every sales dollar is being reinvested or consumed.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRWhat does staying competitive cost, per dollar of sales?
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→The biggest claim on each sales dollar is research and development, at 145% of revenue (stock compensation 61%, capital spending 2%). That share has fallen since 2022, so the cost of competing is easing.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRMargins: of every $1 of sales, how much survives each cost layer?
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→Operating margin compressed 242 points to -2191% since 2022. The bottom line is still negative: costs below the operating line eat what is left.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRWhat does it earn on the money it uses?
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→ROE of -20% and ROCE of -62% sit close together, so the returns come from the business itself rather than from borrowing.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRWhat has the market paid for SMR over time?
214.8xP/S today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→At 214.8x sales, the market is paying +341% more than SMR's own 4-year median of 48.7x. Expectations are elevated, so more has to go right to justify the price.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRWhat cash return does the business throw off per dollar of market value?
-33.9%FCF yield today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→Every dollar of market value currently buys -33.9% of annual free cash flow, more than its 4-year median of -11.1% - the cash is cheaper than usual.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRCould it handle its debt if things went wrong?
→Debt isn't clearly tagged in SMR's filings, so treat the balance sheet with extra care rather than assuming zero.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRIs the company's own capital growing?
→The company's own capital grew from $93M in 2023 to $2.1B (+2106%). The business is building book value rather than consuming it.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRHow much goes back, and how much leaks out as stock comp?
→SMR returned no cash to shareholders in the latest filed year: everything is being retained or reinvested.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRHow fast is your ownership being diluted - or concentrated?
→The share count grew 75.6% in 2025, averaging 49.1% a year over three years. Your slice of the company shrinks by that much each year unless earnings grow faster.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRDoes SMR earn more on its capital than that capital costs?
→SMR's return on capital is negative at -61.8% in 2025. The capital in the business is not yet earning anything back.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRSMR has issued or retired shares - did shareholders end up better off?
→SMR's share count history starts from zero, so dilution can't be measured.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
NuScale PowerSMRAre the people running it buying or selling?
→Insiders sold $1.9B on the open market and bought nothing. Many sales are pre-scheduled diversification rather than a view on the price. A further 35 filings were grants, option exercises or tax withholding, which say nothing either way.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30